^{(From left) Dr Siva Kumaran Jayaraman, Acting CEO, Thomson Hospital KD, Dr Melvin Heng Jun Li. Acting Group CEO, TMC Life Sciences, Dr John Low, CEO, OncoCare Medical Malaysia and  Dr. Tay Miah Hiang, CEO, OncoCare Medical Pte Ltd (Singapore) commemorate the partnership at the agreement signing ceremony.}


KOTA DAMANSARA, Sept 6 (Bernama) -- Thomson Hospital Kota Damansara (Thomson Hospital) is pleased to announce an exciting new partnership with OncoCare Medical Malaysia Sdn Bhd (OncoCare), a move which stands to elevate the standards of cancer care in Malaysia and the region.

Under this partnership, the strength of both entities will be combined, bringing together leading Oncologists and Supportive Care Specialists under one state-of-the-art cancer care facility.

Sharing on the natural fit of the partnership, given Thomson and OncoCare’s shared values and vision, Dr Melvin Heng Jun Li, Acting Group Chief Executive Officer of TMC Life Sciences, highlighted that, “Thomson Hospital and OncoCare both prioritise excellence in patient care, innovation, and the continuous pursuit of medical advancements. Our shared values in delivering positive healthcare outcomes make this partnership a powerful alliance that will significantly benefit our patients. We are enthusiastic about the opportunities this collaboration presents and firmly believe it will establish a new standard in oncology care.”
 
Thomson is the first hospital in Malaysia to receive accreditation for its Core and Ambulatory - Cancer Services under the Evaluation & Quality Improvement Programme (EQuIP7) from the Australian Council on Healthcare Standards (ACHS) International, demonstrating commitment to providing quality care.
 
Dr. John Low, Chief Executive Officer of OncoCare Medical Malaysia, sharing his enthusiasm for the partnership, commented, “Our partnership is poised to make a significant impact in the fight against cancer, offering hope and a path forward for all those affected by this challenging disease. Helmed by highly trained oncologists and supported by a team dedicated to providing personalised care with a human touch, this affiliation is a testament to our shared commitment to enhancing patient outcomes and advancing cancer treatment while upholding the highest standards of quality and sustainability.”
 
Through this partnership, Thomson OncoCare will provide comprehensive, patient-centered treatment options through a tumour site-specific approach based on the specialty and clinical interests of the oncologists. This includes innovative oncology clinical trials, that grant patients access to the latest breakthroughs in cancer treatment, along with alternative therapies aimed at significantly enhancing their outcome and quality of life. Regular international tumour board comprised of leading oncology experts and healthcare specialist from across Asia will be held to discuss new and complex cases. This collaborative model aims to improve patient outcomes by leveraging the expertise of various specialists to provide a comprehensive and personalised treatment plan.

The Thomson OncoCare partnership exemplifies the power of strategic collaboration, with the new cancer center emerging as a beacon of hope and innovation in cancer care. Visit www.thomsonhospitals.com.

Source: Advertising.com.my
 
FOR MORE INFORMATION, PLEASE CONTACT:
Name: Rowena Selvarasan
Manager, Group PR & Comms
Email: rowenas@tmclife.com  

--BERNAMA